Environmental and Molecular Mutagenesis · 1991 · 37 citations · 17 references
PharmacyPharmacologyToxicologyCytogeneticsDevelopmental ToxicologyReproductive ToxicologyHematologic ToxicityPerinatal ToxicologyPlacental ToxicologyPrenatal CytogeneticsPrenatal ToxicityPrenatal ToxicologyBenzene ExposureChemical-induced MicronucleiMaternal-fetal ToxicityMicronuclei FormationMicronucleus Frequency AnalysisPeripheral Blood Micronucleus TestTransplacental ExposureTransplacental Genotoxicity
The transplacental cytogenetic effects of benzene were studied by using the micronucleus test of polychromatic erythrocytes (PCE) found in both fetal liver and fetal peripheral blood, and were compared with PCE from maternal bone marrow. Timed-pregnant mice received single intraperitoneal doses of benzene (0, 109, 219, 437, or 874 mg/kg bw) on the 14th day of gestation and were sacrificed 21 hr after injection. Benzene elicited a significant increase (P less than 0.01) in the frequency of micronucleated polychromatic erythrocytes (MNPCE) in fetal liver blood cells (0.55 to 1.36%, control 0.18%) at doses of 219 to 874 mg/kg, and in fetal peripheral blood cells (0.49 to 0.58%, control 0.25%) and maternal bone marrow cells (0.53 to 0.70%, control 0.10%) at doses of 437 and 874 mg/kg. The data demonstrate that benzene is a moderate transplacental clastogenic agent, and that the mouse transplacental micronucleus test using fetal liver blood cells is a potentially more sensitive indicator of the genotoxicity of benzene than either fetal peripheral blood or maternal bone marrow cells.
17
Benzene as a leukemogenic and carcinogenic agent
Muzaffer Aksoy · American Journal of Industrial Medicine · 1985 · 102 citations
Medicine, Hematology, Oncology +16